- Home
- » Tags
- » Neuroprotection
Top View
- Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proin
- Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits
- Cerebrospinal Fluid Concentrations of N-Acetylcysteine After Oral
- Metabotropic Glutamate Receptors As Targets for Multipotential Treatment of Neurological Disorders
- Effects of Postresuscitation N-Acetylcysteine on Cerebral Free Radical Production and Perfusion During Reoxygenation of Hypoxic Newborn Piglets
- The Kynurenine Pathway: a Primary Resistance Mechanism in Patients with Glioblastoma Peter P
- Neuroprotection Signaling Pathway of Nerve Growth Factor and Brain-Derived Neurotrophic Factor Against Staurosporine Induced Apoptosis in Hippocampal H19-7 Cells
- Role of Tumor Necrosis Factor-Αin Methamphetamine- Induced Drug
- Therapeutic Potential of Brain-Derived Neurotrophic Factor (BDNF) and a Small Molecular Mimics of BDNF for Traumatic Brain Injury
- Brain-Derived Neurotrophic Factor-Mediated Neuroprotection Of
- Clinical Trials of New Drugs for Alzheimer Disease Li-Kai Huang1,2†, Shu-Ping Chao1,3† and Chaur-Jong Hu1,2,4,5*
- Caffeine Inhibits Notum Activity by Binding at the Catalytic Pocket
- Biological Bases for a Possible Effect of Cannabidiol in Parkinson's Disease
- Neuroprotection by Cannabinoids in Neurodegenerative Diseases
- Neuroprotection Or Neurotoxicity of Illicit Drugs on Parkinson's Disease
- Mechanisms of Progesterone-Induced Neuroprotection
- Environmental Enrichment-Mediated Neuroprotection Against Traumatic Brain Injury:Role of Brain-Derived Neurotrophic Factor
- Transcriptional Pharmacology of Neurodegenerative Disorders: Novel Venue Towards Neuroprotection Against Excitotoxicity?
- Disease Modification and Neuroprotection in Neurodegenerative Disorders Jeffrey Cummings
- Brainstorms: Excitotoxicity and Neuroprotection
- Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury
- The Biochemical Effectiveness of N-Acetylcysteine in Experimental Spinal Cord Injury in Rats
- The Effect of Caffeine on the Risk and Progression of Parkinson's
- Amyotrophic Lateral Sclerosis Is Accompanied by Protein Derangements in the Olfactory Bulb-Tract Axis
- Ars.2017.7493.Pdf
- Neuroprotection: L Wheeler, R Lai, E Woldemussie and WA Hare New Pharmacological Targets
- Anti-Inflammatory Pro-Resolving Mediators with Therapeutic Potential
- Neuroprotective Natural Products for Alzheimer's Disease
- Metabotropic Glutamate Receptors in Main- Taining the Level of Extracellular Glutamate in Ischemic Stroke and Neurodegenerative Diseases
- Recovery of Dopamine Transporters with Methamphetamine Detoxification Is Not Linked to Changes in Dopamine Release
- Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis
- Neuroprotection by Tetrahydrocannabinol in an in Vivo Excitotoxicity-Model As Studied by Diffusion-Weighted and T2-Weighted MRI
- Synergistic Neuroprotection by Coffee Components Eicosanoyl-5-Hydroxytryptamide and Caffeine in Models of Parkinson’S Disease and DLB
- Role of Edaravone As a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
- The Neuroprotective Potential of Low-Dose Methamphetamine in Preclinical Models of Stroke and Traumatic Brain Injury
- Neuroprotective Strategy for Alzheimer Disease: Intranasal Administration of a Fatty Neuropeptide I
- Quinolinic Acid Is Associated with Cognitive Deficits in Schizophrenia
- Antioxidant Cascades Confer Neuroprotection in Ethanol, Morphine, and Methamphetamine Preconditioning T
- Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy
- NAC-Loaded Electrospun Drug Delivery Scaffolding For
- N-Acetylcysteine
- Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer
- N-Acetylcysteine (NAC): Impacts on Human Health
- Neuroprotection and Axonal Regeneration After Peripheral Nerve Injury
- Neuregulin 1 Confers Neuroprotection in SOD1-Linked Amyotrophic Lateral
- Neuroprotection in Early Stages of Alzheimer's Disease Is Promoted By
- Understanding the Mechanisms of Acetyl-L-Carnitine Through Neuroprotection After Methamphetamine Administration
- CD Pretreatment Induces Neuroprotection in an in Vitro Model of Alzheimer’S Disease: a Transcriptomic Study
- Serum Caffeine and Metabolites Are Reliable Biomarkers of Early Parkinson Disease Motoki Fujimaki, Shinji Saiki, Yuanzhe Li, Et Al
- Neuroprotective Effects and Mechanisms of Tea Bioactive
- Neuroprotective Effects of Delta-9-Tetrahydrocannabinol Against Feso4- and H2O2-Induced Cell Damage on Dopaminergic Neurons in Primary Mesencephalic Cell Culture
- Neuroprotection on Multiple Sclerosis: a BDNF Perspective
- Role of Kynurenine Pathway in Oxidative Stress During Neurodegenerative Disorders
- N-3 Docosapentaenoic Acid-Derived Protectin D1 Promotes Resolution of Neuroinflammation and Arrests Epileptogenesis